Sanofi
corporate_fare Company Profile
Sanofi (NASDAQ:SNY) is a publicly traded company in the Life Sciences sector. Wiseek monitors SNY SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Sanofi Ends Amlitelimab Push in Atopic Dermatitis and Overhauls Executive Committee
- FDA Approves First On-Body Injectable for Multiple Myeloma, Sanofi's Sarclisa Escena
- Sanofi's Nexviazyme Achieves Positive Phase 3 Results for Infantile-Onset Pompe Disease
- Sanofi's Nexviazyme Hits All Endpoints in Phase 3 for Infantile Pompe Disease
- Sanofi Secures EU Approval for First Disability-Targeting MS Drug, Two Japan Approvals, and New R&D Head
Financial Snapshot
Insider Transactions
SNY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.